Fig. 3From: MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancerExpression of miR-26b-5p and MYCBP in TNBC patients. A MiR-26b-5p levels were significantly lower in TNBC tissues (n = 60) than in adjacent nontumor tissues (ANT, n = 26). B The expression of miR-26b-5p in 20 pairs of TNBC tissues and matched ANT was determined using PCR assay. C MYCBP levels were significantly higher in TNBC tissues (n = 60) than in ANT (n = 26). D The expression of MYCBP in 20 pairs of TNBC tissues and matched ANT was determined using PCR assay. E The correlation between miR-26b-5p and MYCBP expression in TNBC tissues was determined by Spearman’s correlation analysisBack to article page